Epstein-Barr virus-associated gastric carcinoma

MONDO:0017784

Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC) is a rare form of gastric carcinoma (seen in approximately 10% of cases) with a male predominance, characterized by a latent EBV infection in gastric carcinoma cells, diffuse-type histology, a proximal location (in the body and cardia of the stomach) and a relatively favorable prognosis.

Also known as: EBV-associated gastric carcinoma, EBVaGC

2875 clinical trials for this condition and its sub-types, 1 tagged with Epstein-Barr virus-associated gastric carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Gastric carcinoma (555) ↑ Epstein-Barr virus-associated carcinoma (214)

Including sub-types (2875) Tagged with Epstein-Barr virus-associated gastric carcinoma (1)

Trials to join now! 1

New drug cocktail targets Virus-Linked cancers in early trial

Disease control Recruiting now

This phase 1 study tests a combination of two drugs, pomalidomide (a pill) and nivolumab (an infusion), in adults with cancers caused by viruses like Epstein-Barr, HPV, or hepatitis. The goal is to find a safe dose and see if the drugs can shrink tumors. Up to 58 people with Kapo…

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Sep 19, 2026 00:00 UTC

Epstein-Barr virus-associated gastric carcinoma

Where it sits in the disease tree

New drug cocktail targets Virus-Linked cancers in early trial